US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist

158.710
+0.810+0.51%

Close Nov 25 16:00 ET

159.100
+0.390+0.25%

Post 20:01 ET

23.13BMarket Cap14.35P/E (TTM)

Biogen Key Stats

Biogen Q3 2024 Earnings Date

Currency：USDOct 30, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	2.43B	2.47B	+31.13M
Beat Est.	-3.78%	-2.55%	+1.28%
EPS	3.01	2.66	-0.35
Miss Est.	+741.33%	+665.96%	-11.73%

Analyst Rating

Buy

Nov 25, 2024

Biogen Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 2.318B	--
--	2024/Q4	-- / 2.419B	--
Oct 30, 2024	2024/Q3	2.466B / 2.435B	--
Aug 1, 2024	2024/Q2	2.465B / 2.386B	--
Apr 24, 2024	2024/Q1	2.291B / 2.315B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 2.318B--

--2024/Q4-- / 2.419B--

Oct 30, 20242024/Q32.466B / 2.435B--

Aug 1, 20242024/Q22.465B / 2.386B--

Apr 24, 20242024/Q12.291B / 2.315B--

Unlock Free Earnings Estimates

Open Account

Biogen Earnings Reports

Biogen | 10-Q: Q3 2024 Earnings Report

Oct 30 16:33 ET

Biogen | 8-K: Biogen reports third quarter 2024 results and raises full year 2024 financial guidance

Oct 30 06:57 ET

Biogen | 10-Q: Q2 2024 Earnings Report

Aug 1 16:17 ET

Biogen | 8-K: Biogen reports strong second quarter 2024 results and raises full year 2024 financial guidance; Second quarter 2024 total revenue of $2.5 billion, GAAP diluted EPS of $4.00 and Non-GAAP diluted EPS of $5.28

Aug 1 06:57 ET